Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 2 hours ago

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 30, Status: Authorised

about 3 hours ago

Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation...

Sponsor guidance: New safety module on the annual safety report

about 3 hours ago

Sponsor guidance: New safety module on the annual safety report

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation: 02/06/2025, Revision: 4, Status: Withdrawn

about 3 hours ago

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Date of authorisation...

Fifth European Medicines Agency and Nuclear Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 10 July 2026

about 4 hours ago

Fifth European Medicines Agency and Nuclear Medicines Europe bilateral meeting, Online, European...

List of centrally authorised products with safety-related changes to the product information

1 day ago

List of centrally authorised products with safety-related changes to the product information

Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation: 25/11/2009, Revision: 23, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation...

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 33, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation...

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 14, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation...

Start of procedure: Extension of marketing authorisation (26 June 2026 - 23 July 2026)

about 10 hours ago

Start of procedure: Extension of marketing authorisation (26 June 2026 - 23...